U.S., April 12 -- ClinicalTrials.gov registry received information related to the study (NCT06923826) titled 'Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)' on March 12.
Brief Summary: The goal of this clinical trial is to learn if the drug, sacituzumab govitecan, works to treat:
1. Salivary gland cancers that have spread to other parts of the body or come back after previous treatment, and cannot be removed by surgery
2. A type of thyroid cancer (specifically, differentiated thyroid carcinoma) that has spread to other parts of the body or come back after previous treatment, no longer responds to radioactive iodine treatment and cannot be removed by surgery
The main question it aims to answer is whethe...